Literature DB >> 10459575

Overproduction of insulin in the chromium-deficient rat.

J S Striffler1, M M Polansky, R A Anderson.   

Abstract

The hypothesis that the insulin secretory hyperresponsiveness observed in rats with diet-induced insulin resistance may be a basic characteristic of dietary chromium (Cr) deficiency was evaluated. Two groups of weanling rats were fed ad libitum a purified diet containing 64% sucrose, 20% casein, 5% corn oil, and the recommended levels of vitamins and minerals without added Cr. Cr-deficient (-Cr) rats were provided with distilled drinking water only, while Cr-supplemented (+Cr) rats received water containing 5 ppm Cr as CrCl3. A third group of rats fed a commercial chow diet served as sucrose controls. Effects of Cr deficiency were assessed by comparing fasting levels of glucose, insulin, and plasma lipids in blood samples collected biweekly from the -Cr and +Cr groups over a 3-month period. Both groups of rats fed the low-Cr sucrose diet developed a transient hyperinsulinemia and hyperlipidemia relative to the chow-fed control rats. There were significant effects of Cr supplementation on plasma triglycerides during the initial 2 weeks of dietary adaptation. Effects of the low-Cr diet were evaluated after the 12-week period by comparing the insulin response area and glucose clearance during a 40-minute intravenous glucose tolerance test (IVGTT). The rates of glucose clearance (KG) in -Cr and +Cr rats were similar (4.2 +/- 1.0 and 4.3 +/- 0.8%/min, respectively) and were comparable to the K(G) in chow-fed rats (4.6 +/- 0.8). In contrast, insulin secretory responses in -Cr rats were exaggerated (area, 14,083 +/- 3,399 microU/mL x min), being twofold greater (P < .05) relative to the +Cr group (6,183 +/- 864). The insulin secretory response area in chow-fed rats (7,081 +/- 408 microU/mL x min) was similar to the value in the +Cr group. These observations provide support for the hypothesis that Cr deficiency can lead to elevated insulin secretory responses to glucose.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10459575     DOI: 10.1016/s0026-0495(99)90207-x

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  4 in total

1.  Long-term exposure to [Cr(3)O(O (2)CCH (2)CH (3)) (6)(H (2)O) (3)] (+) in Wistar rats fed normal or high-fat diets does not alter glucose metabolism.

Authors:  Betty J Herring; Amanda L Logsdon; Jarrett E Lockard; Brittany M Miller; Hanna Kim; Eric A Calderon; John B Vincent; Melissa M Bailey
Journal:  Biol Trace Elem Res       Date:  2012-12-29       Impact factor: 3.738

2.  Chromium is not an essential trace element for mammals: effects of a "low-chromium" diet.

Authors:  Kristin R Di Bona; Sharifa Love; Nicholas R Rhodes; DeAna McAdory; Sarmistha Halder Sinha; Naomi Kern; Julia Kent; Jessyln Strickland; Austin Wilson; Janis Beaird; James Ramage; Jane F Rasco; John B Vincent
Journal:  J Biol Inorg Chem       Date:  2010-11-18       Impact factor: 3.358

3.  Oral administration of the biomimetic [Cr3O(O2CCH2CH3)6(H2O)3]+ increases insulin sensitivity and improves blood plasma variables in healthy and type 2 diabetic rats.

Authors:  Buffie J Clodfelder; Bryan M Gullick; Henry C Lukaski; Yasmin Neggers; John B Vincent
Journal:  J Biol Inorg Chem       Date:  2004-12-30       Impact factor: 3.358

4.  Conversion of Chromium(III) Propionate to Chromate/dichromate(VI) by the Advanced Oxidation Process. Pretreatment of a Biomimetic Complex for Metal Analysis.

Authors:  D Lynn Rodman; Nathan A Carrington; Zi-Ling Xue
Journal:  Talanta       Date:  2006-10-15       Impact factor: 6.057

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.